Facultative to strict anaerobes ratio in the preterm infant microbiota: A target for intervention? by Arboleya, Silvia et al.
1 
 
Facultative to strict anaerobes ratio in the preterm infant microbiota: a 
target for intervention? 
 
 
Silvia Arboleya1, Gonzalo Solís2, Nuria Fernández3, Clara G. de los Reyes-
Gavilán1 and Miguel Gueimonde1* 
 
1 Department of Microbiology and Biochemistry, Instituto de Productos Lácteos 
de Asturias (IPLA-CSIC), Villaviciosa, Asturias, Spain. 
2 Paediatrics Service, Hospital Universitario Central de Asturias, SESPA, 
Oviedo, Asturias, Spain.  
3 Paediatrics Service, Hospital Cabueñes, SESPA, Gijón, Asturias, Spain 
 
* Corresponding author: Miguel Gueimonde. Department of Microbiology and 
Biochemistry of Dairy Products. Instituto de Productos Lácteos de Asturias. 
CSIC. Ctra. Infiesto s/n, 33300 Villaviciosa, Asturias, Spain. Tel. +34 
985892131, Fax. +34 985892233. E-mail; mgueimonde@ipla.csic.es 
 
Addendum to: Arboleya S, Binetti A, Salazar N, Fernández N, Solís G, 
Hernández-Barranco A, et al. Establishment and development of intestinal 
microbiota in preterm neonates. FEMS Microbiol Ecol 2012; 79:763-72. 
 
Key words: Preterm neonates, infants, intestinal microbiota, anaerobes, 
facultative anaerobes 
 
2 
 
 Abstract 
During recent years there has been an increasing interest on the development 
of strategies for modulating the process of microbiota establishment in preterm 
infants. For successfully developing such strategies a detailed knowledge of the 
microbiota establishment process in these infants is needed. In a previous study 
we evidenced clear alterations in the process of microbiota establishment in 
preterm newborns when compared with a control group of full-term breast-fed 
infants. Here we have analyzed these data more in depth, corroborating a 
reduced proportion of strict anaerobes with respect to facultatives in the fecal 
microbiota of preterm infants. The potential benefits, as well as the side-effects, 
of strategies aimed at counterbalancing this alteration in the facultative to strict 
anaerobes ratio are discussed in this addendum. 
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Introduction 
The basis of a healthy intestinal microbiota lies in early infancy, the initial 
establishment of the microbiota being a key step for the long term well-being.1 
This establishment starts with facultative anaerobes such as enterobacteria and 
enterococci and continues with anaerobic genera, including Bifidobacterium, 
Bacteroides, and Clostridium. The mode of delivery, feeding habits or use of 
medication, among other factors, may affect this process.2 These initial stages 
of microbiota development may be the appropriate time for microbiota 
modulation towards the establishment of a healthy microbial profile in the 
individual.  
Breast-milk is known to play an important role in the establishment of the 
intestinal microbiota as well as on the later health of the infant.3 This has led to 
the consideration of the fecal microbiota profile of the healthy full-term, 
vaginally-delivered, exclusively breast-fed (FTVDBF) infant as the standard for 
a healthy infant microbiota.  
Preterm infants, especially those born before week 28, present an 
immature immune system4 and a compromised gut mucosa with increased 
permeability.5 These represent a risk for infection, at the first moment for 
vertically transmitted infections, and later on for late-onset nosocomial 
infections. Nosocomial sepsis in preterm infants is often related to the use of 
catheters; thus, Gram + microorganisms belonging to the genus 
Staphylococcus are the main causative agent followed by Gram – bacteria, in 
most cases E. coli or Klebsiella,6,7 these  Gram – microorganisms promoting the 
higher morbidity and mortality rate. In addition, in preterm newborns the process 
of microbiota establishment is altered, likely due to organ immaturity, the 
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frequent use of antibiotics and the stay at the Hospital Neonatal Unit. In general, 
colonization by commensals seems to be delayed and there is an increased 
colonization by potential pathogenic microorganisms.8 Premature infants also 
present an increased risk for developing necrotizing enterocolitis (NEC) and in a 
significant number of cases these infants suffering NEC develop sepsis, mainly 
due to enterobacteria, in which the intestinal microbiota is suspected to be the 
source of infection. Therefore, preterm infants would benefit from intervention 
strategies directed at favoring the establishment of a healthy microbiota. 
However, in order to select the best suited intervention strategies to counteract 
microbiota aberrancies, a detailed knowledge of the intestinal microbiota 
composition and activity in the target population, such as preterm infants, is 
needed.9 
Different studies reported on the administration of pro- and prebiotics to 
preterm newborns without evidencing adverse events.10-15 Moreover, some 
beneficial effects of probiotic and prebiotic administration to preterm neonates 
have been observed. Recent reviews and meta-analysis have reported benefits 
of supplementation with some probiotic strains, especially relating to prevention 
of NEC16-18 and guidelines for probiotic use in preterm infants have been 
published.19 With regard to prebiotics a meta-analysis of randomized controlled 
trials indicated that prebiotic-supplemented formula increases the levels of 
bifidobacteria and lactobacilli in premature newborns without adverse effects.20 
However, the current evidence is still insufficient to allow extracting conclusions 
regarding prebiotics clinical use in preterm babies.21  
Microbiota establishment in preterm neonates 
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We have recently studied the process of establishment of the intestinal 
microbiota in preterm infants (n=21, mean gestational age 32.7 weeks, 
birthweights ranging from 1190 to 2820 gr) and compared it with that of 
FTVDBF healthy neonates (n=20, mean gestational age 39.3 weeks, 
birthweights 3020-4160 gr), by using DGGE, SCFAs analyses and quantitative 
PCR for eighteen different microbial groups (including, among others, 
predominant intestinal microorganisms such as Bacteroides group, Clostridium 
leptum group, Blautia coccoides group, Lactobacillus group, Bifidobacterium, 
Enterobacteriaceae, Enterococcaceae or Streptococcus, as well as potentially 
pathogenic bacteria such as Klebsiella pneumoniae, Weissella, Staphylococcus 
aureus, Clostridium perfringens or Clostridium difficile).22 We observed 
noticeable quantitative differences in the levels of several microbial populations 
between both groups of infants during the first three months of life. Preterm 
infants harbored higher levels of Enterobacteriaceae, Lactobacillus, 
Enterococcaceae and Weissella, among others. More specifically these infants, 
showed increased numbers of K. pneumoniae, a relevant nosocomial 
pathogenic microorganism in this population.6 On the opposite, preterm babies 
had lower levels of Bifidobacterium, Bacteroides and Atopobium. All together 
these observations seem to indicate a deficiency in the establishment of the 
normal anaerobic gut microbiota in preterm newborns, as suggested by the 
increased levels of most facultative anaerobic microorganism, such as 
Enterobacteriaceae, Enterococcaceae or Weissella, together with the reduced 
levels of strict anaerobes. Therefore, it could be hypothesized that the 
differences found between preterm and FTVDBF newborns respond to different 
gut-environment factors rather than to any specific microbial groups. 
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In the present addendum we calculated the percentages of each bacterial 
group with regard to the total number of microorganisms quantified (Figure 1). 
Enterobacteriaceae ranged between 45 to 63% of total microorganisms in 
FTVDBF infants, whereas they represented 60 to 83% in the preterm group. 
Among the non-Enterobacteriaceae microorganisms, Bacteroides, 
Enterococcaceae and Streptococcus, followed by Bifidobacterium were 
predominant at 2 days of age in feces from FTVDBF babies. In the preterm 
group, however, the predominant microorganisms at this time were 
Enterococcaceae and Lactobacillus group, followed by Streptococcus. Between 
10 days and 3 months of age Bifidobacterium and Bacteroides predominate in 
FTVDBF infants, in contrast with the dominance of Enterococcaceae and 
lactobacilli observed in premature babies.  
Facultative and strict anaerobes in preterm neonates 
Overall we estimated the proportions of facultative and strict anaerobes by 
the sum of the corresponding microbial groups (Enterobacteriaceae, 
Enterococcaceae, lactobacilli group, Weissella, Streptococcus and 
Staphylococcus for facultatives and Bifidobacterium, Bacteroides group, 
Clostridium cluster IV, Clostridium cluster XIVa and Atopobium group for strict 
anaerobes) and found statistically significant differences between both infant 
groups during the first three months of life (Figure 2). 
To further assess this empirical observation of altered facultative and strict 
anaerobes levels, we used a mathematical approach, by means of factorial 
analysis, for grouping the different microbial populations quantified in our 
previous study.22 This analysis evaluates the existence of linear relationships 
among variables (microbial groups), grouping them into “factors” if such 
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relationships do exist. To this end those microbial groups detected in our 
previous study at very low frequencies (such as Clostridium difficile, 
Desulfovibrio, Clostridium perfringens, Shigella, Staphylococcus aureus or 
Akkermansia) , and therefore not likely being members of the normal gut 
microbiota of newborns, were excluded from the analysis. The factorial analysis 
using correlation matrices and Principal Component Analysis as extraction 
method (SPSS software; SPSS Inc., Chicago, USA), was then applied to the 
data. Three main factors, showing eigenvalues higher than 1 (3.27, 2.44 and 
1.41, respectively) and explaining 25, 19 and 11% of variance, respectively, 
were obtained. These factors clustered the original variables corresponding to 
specific microbial groups. For the first factor the variables showing higher 
coefficients were Weisella, Enterobacteriaceae, lactobacilli and 
Enterococcaceae, all of them facultative anaerobic microorganisms. The 
second factor included Bifidobacterum, Bacteroides, Atopobium and Clostridium 
clusters IV and XIVa, all of them strict anaerobes. This prompted us to define 
these factors as “facultatives” and “anaerobes”, respectively. Interestingly the 
third factor grouped staphylococci and streptococci, the numerically 
predominant microorganisms found in breast milk,23 thus being named “breast-
milk” factor. 
The values obtained from each infant’s fecal sample, for these newly 
created factors, were used for comparing between preterm and FTVDBF 
newborns at different time points during the first three months of life (2, 10, 30 
and 90 days of age). At 2 days of age the three factors showed statistically 
significant differences between both groups of infants (ANOVA, p<0.05), 
“facultatives” showing a higher value in preterms whilst the contrary was 
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observed for “anaerobes” and “breast-milk”. At later sampling points only the 
factors “facultatives” and “anaerobes” differed significantly (p<0.05 for both 
factors at 10, 30 and 90 days) being higher and lower, respectively, in 
premature infants (data not shown). Thus, these two factors allowed 
discriminating between both infant populations during the first months of life 
(Figure 3).  
With regard to the factor “breast-milk” the difference observed at 2 days, 
but not at later sampling points, could be probably related with the feeding habit 
of the infants. All infants in the control group (FTVDBF) were exclusively breast-
fed during the whole duration of the study, whilst none of the preterm infants 
was exclusively in breast-feeding. In our cohort at 2 days of age only 2 preterm 
infants were exclusively breast-fed, 3 were on mixed feeding and 16 were on 
formula, whilst at 10 days only 3 infants remained exclusively formula-fed. 
These differences in feeding habits are very likely the explanation for the 
differences obtained for the factor “breast-milk” at 2 days of age. 
The factorial analyses of microbial groups in FTVDBF and premature 
babies commented just above appears to support our initial empirical 
observation of reduced levels of strict anaerobic microorganisms and increased 
facultatives in preterm infants. Therefore, it can be speculated that the 
differences between both groups of infants may be based on an altered 
oxidative environment in the gut rather than on differences on specific 
microorganisms, although other factors may be involved as well. Noteworthy, in 
an animal model it has been shown by other authors that the environmental 
parameter having the strongest influence on the intestinal bacterial community 
was the redox potential.24 
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On this basis it can be hypothesized that nutritional interventions aimed at 
increasing strict anaerobes and reducing the levels of facultative anaerobic 
microorganisms, which include several potentially pathogenic bacteria, may be 
beneficial for preterm infants. 
Intestinal oxidative stress as a potential target for microbiota modulation 
in preterm neonates 
At birth the neonate must adapt from the hypoxic fetal environment to the 
relatively hyperoxic atmospheric environment, which causes an important 
oxidative stress. Moreover, very often preterm infants are oxygenated with high 
concentrations of O2. Recent studies have demonstrated that premature birth is 
associated with an increased oxidative stress, and damage promoted by 
reactive oxygen species that are not properly managed by the immature 
antioxidant systems of preterm babies.25-28 This increased level of oxidative 
stress has been related to the risk for the so called “free radical-related 
diseases”, such as retinopathy, bronchopulmonary dysplasia and, at intestinal 
level, NEC29 which are often associated with preterm birth. Interestingly, breast-
milk from mothers of full-term infants has been found to have a higher 
antioxidant capacity than that of mothers of preterm babies.30 These findings 
have prompted researchers to focus their attention on antioxidant 
supplementations in preterm babies by the use of non-enzymatic proteins, such 
as transferrin and ferritin, antioxidant enzymes or oxidizable molecules, 
including vitamins, fatty acids or aminoacids, among others,26,27 for some of 
which positive results have been published.31,32 Interestingly, probiotic 
microorganism could also play a role as antioxidants, since strains displaying 
this property have been reported33 and probiotic metabolites able to prevent the 
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production of proinflammatory cytokines induced by oxidative stress have been 
recently identified.34 
Therefore, in the context of nutritional interventions the inclusion on infant 
formula of antioxidants, able to reduce the redox potential also in the intestine, 
represents a hypothetical, but nevertheless attractive, approach for microbiota 
modulation in preterm infants. Despite the potential beneficial effects of such 
interventions on terms of microbiota composition, by reducing the levels of 
facultative anaerobes which include the most relevant nosocomial infectious 
agents for this infant population,6,7 no attention has ever been paid to the effect 
of such interventions on intestinal microbiota in these infants. However, in 
addition to the potential benefits of such strategy there are also some potentially 
deleterious effects that should be carefully evaluated. Among these the risk of 
bowel isquemia should be considered. A study that, although controversial, 
underlines this point is that of Besselink et al.35 in which the use of enterally 
administered probiotics to reduce pathogen overgrowth in patients with severe 
acute pancreatitis was studied. The authors did not find significant differences 
between groups in infectious complications or in new onset organ failure, but 
the test group doubled the mortality rate as compared with the placebo group, 
and bowel ischemia was detected during surgery or autopsy in nine patients in 
the probiotics group and none in the placebo group. The authors suggested that 
enteral administration of probiotics further increased local oxygen demand, with 
a combined deleterious effect on an already critically reduced blood flow. 
Although, these results should be taken with caution36 this study highlights the 
need of a careful safety evaluation of any intervention in highly susceptible 
populations. 
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Current and future challenges 
In preterm infants the main benefits of microbiota modulation would 
include the enhanced maturation of the immune system and the reduction in the 
number of potentially pathogenic microorganisms that may cause infection in 
this highly susceptible population. Our results underline the global differences 
occurring on the process of establishment of the intestinal microbiota in preterm 
infants when compared with the healthy standard population (FTVDBF infant). 
This may be of help for designing new intervention strategies targeting the gut 
microbiota in order to minimize the risk of infection and/or NEC in these infants. 
However, it must be pointed out that more research is needed to assess 
whether that of FTVDBF infants represents a good microbiota model also for 
preterm infants. In addition our results did not include data on extreme-preterm-
infants, which would be the group that could benefit the most from microbiota 
modulation, but for which we do not really know whether the same differences 
do exist. 
It is worth mentioning that, similarly as for preterm neonates and NEC 
where both oxidative stress29 and microbiota factors37,38 seem to play a role, 
inflammatory bowel disease is another situation in which the microbiota has 
been found to be altered39 and for which a role of oxidative stress as patho-
physiological factor has been reported.40 This suggests that oxidative stress 
may be an important factor driving the microbiota composition in different 
inflammatory diseases. 
In this addendum we look at our previous data from a different perspective 
and tried to understand what the global microbiota composition of preterm 
infants may tell us in terms of environmental conditions. This allowed us to 
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speculate that oxidative stress may be an important factor shaping the gut 
microbiota in these infants and, therefore, it also represents a potential target 
for intervention. This hypothesis is just speculative and should now be 
experimentally tested. To this regard, we suggest to consider the microbiota 
among the potential beneficial targets in intervention studies aiming at reducing 
the oxidative stress in preterm infants. 
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Figure 1. Percentages of different fecal microbial groups, in both groups of 
infants, at 2, 10, 30 and 90 days of age. 
Figure 2. Percentages of facultative anaerobes and strict anaerobes in 
premature and full-term infants at the different time points analyzed. 
Statistical comparison (U Mann-Whitney) between both groups. 
Figure 3. Scatter-gram of the infant samples at the different sampling points 
according to the values obtained for the factors “facultatives” and 
“anaerobes”. Open circles: Full-term, vaginaly-delivered, exclusively breast-
fed babies. Close circles: Preterm babies. 
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